My Watchlist
Subscribe and get alerts for the stocks and topics you follow
|
|
Genzyme Corp. (GENZ)
Add to Watchlist
|
|
short-termtrading.blogspot.com
-
Jan 05, 2009
about
GOOG, CMCSA, RIMM and 27 moreDELL, AMGN, SIRI, COST, AMAT, TLAB, EBAY, YHOO, GILD, BRCM, AMZN, AKAM, VRSN, ORCL, NVDA, JAVA, CSCO, SBUX, DISH, QCOM, MSFT, INTC, NTAP, JNPR, GENZ, ADBE, AAPL
Support at 1150 for the emini nasdaq (@nq). The Index is testing the resistance at 1250. Many are betting on a failed breakout. Next resistance at 1400. I think the market will continue the rebound although general conditions remain pretty weak for the moment. Very interesting, most stocks are tr...
|
|
|
short-termtrading.blogspot.com
-
Dec 29, 2008
about
GOOG, CMCSA, RIMM and 27 moreDELL, AMGN, SIRI, COST, AMAT, TLAB, EBAY, YHOO, GILD, BRCM, AMZN, AKAM, VRSN, ORCL, NVDA, JAVA, CSCO, SBUX, DISH, QCOM, MSFT, INTC, NTAP, JNPR, GENZ, ADBE, AAPL
GILD is the only stock trading above the 3 moving averages (20, 50, 100).In the Figure you can see a summary of the trend conditions of the Index stocks. I used the 20, 50, 100 and 200 days moving average of the close. The background is Green when the close is > than the moving average. Red when...
|
|
|
The market's sharp downturn in recent months has decimated investors' portfolios amid financial turmoil.
|
|
|
BioMarin's Kuvan is tentatively given the thumbs up in Europe.
|
|
|
investors.com
-
Sep 15, 2008
about
GENZ
Some drug companies want to hit home runs with blockbuster drugs. Genzyme (GENZ) is content to bat out singles with a widely diversified portfolio...
|
|
|
fundmymutualfund.com
-
Aug 15, 2008
about
AMLN, DNA, VRTX and 16 moreGLD, FBT, OSIP, GENZ, CEPH, XBI, PDLI, AMGN, IMCL, AFFX, GILD, BIIB, BBH, CELG, ILMN, IF
One area you can see I've been transitioning into is healthcare. I still don't buy the "technology is a safe haven" thesis but I have to respect that's where money flow is going. Healthcare I can feel a bit more comfortable with because it's a traditional safe haven in times of recession. Not tha...
|
|
|
|
|
